...
首页> 外文期刊>Scientific reports. >Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows
【24h】

Genomic analysis and immune response in a murine mastitis model of vB_EcoM-UFV13, a potential biocontrol agent for use in dairy cows

机译:vB_EcoM-UFV13鼠乳腺炎模型中的基因组分析和免疫应答,一种可用于奶牛的潜在生物防治剂

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Bovine mastitis remains the main cause of economic losses for dairy farmers. Mammary pathogenic Escherichia coli (MPEC) is related to an acute mastitis and its treatment is still based on the use of antibiotics. In the era of antimicrobial resistance (AMR), bacterial viruses (bacteriophages) present as an efficient treatment or prophylactic option. However, this makes it essential that its genetic structure, stability and interaction with the host immune system be thoroughly characterized. The present study analyzed a novel, broad host-range anti-mastitis agent, the T4virus vB_EcoM-UFV13 in genomic terms, and its activity against a MPEC strain in an experimental E. coli-induced mastitis mouse model. 4,975 Single Nucleotide Polymorphisms (SNPs) were assigned between vB_EcoM-UFV13 and E. coli phage T4 genomes with high impact on coding sequences (CDS) (37.60%) for virion proteins. Phylogenetic trees and genome analysis supported a recent infection mix?between vB_EcoM-UFV13 and Shigella phage Shfl2. After a viral stability evaluation (e.g pH and temperature), intramammary administration (MOI 10) resulted in a 10-fold reduction in bacterial load. Furthermore, pro-inflammatory cytokines, such as IL-6 and TNF-α, were observed after viral treatment. This work brings the whole characterization and immune response to vB_EcoM-UFV13, a biocontrol candidate for bovine mastitis.
机译:牛乳腺炎仍然是奶农经济损失的主要原因。乳原性大肠杆菌(MPEC)与急性乳腺炎有关,其治疗仍基于使用抗生素。在抗菌素耐药性(AMR)时代,细菌病毒(噬菌体)是一种有效的治疗方法或预防方法。但是,这必须对它的遗传结构,稳定性和与宿主免疫系统的相互作用进行全面表征。本研究从基因组角度分析了一种新型的,广泛的宿主范围抗乳腺炎药物,T4病毒vB_EcoM-UFV13及其在实验性大肠杆菌诱导的乳腺炎小鼠模型中对MPEC株的活性。在vB_EcoM-UFV13和大肠杆菌噬菌体T4基因组之间分配了4,975个单核苷酸多态性(SNP),这对病毒体蛋白的编码序列(CDS)有很高的影响(37.60%)。系统发育树和基因组分析支持了vB_EcoM-UFV13和志贺氏菌噬菌体Shfl2之间最近的感染混合。在病毒稳定性评估(例如pH和温度)之后,乳内给药(MOI 10)导致细菌载量减少10倍。此外,在病毒治疗后,观察到促炎细胞因子,例如IL-6和TNF-α。这项工作为牛乳腺炎的生物防治候选药物vB_EcoM-UFV13带来了完整的表征和免疫应答。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号